The Washington Post

Recent posts by The Washington Post

States move to ban fake urine, a new challenge for drug testing in age of opioid epidemic, legal marijuana

With the nation’s opioid crisis raging, rates of cocaine and methamphetamine abuse soaring and recreational marijuana use becoming legal in nine states and the District of Columbia, the concern about clean drug tests, too, has increased.

Google and Facebook won’t advertise marijuana, even where it’s legal

As the cannabis industry grows, generating an estimated $10 billion in annual sales, states are increasingly approving medical marijuana programs and passing adult-use laws. But for marketing agencies, marijuana dispensaries and cannabis brands, advertising the pot brings its own hurdles.

Cannabis sales forecast suggests it may surpass soda by 2030

The U.S. legal cannabis industry is expected to reach $75 billion in sales by 2030, according to research firm Cowen & Co. That’s almost as large as the North American carbonated soft drink market in 2017.

More on the two new studies showing how marijuana can help fight the opioid epidemic

“These findings further strengthen arguments in favor of considering medical applications of cannabis as one tool in the policy arsenal that can be used to diminish the harm of prescription opioids,” the authors of one report concluded.

Here’s how much marijuana you’d need to be eligible for the death penalty under federal law

Last week Attorney General Jeff Sessions issued a memo encouraging federal prosecutors to seek the death penalty for certain drug trafficking offenses. Here’s how much marijuana you’d need to be eligible for the death penalty under federal law.

In the murky world of D.C. marijuana law, “pop-up” markets thrive

Some vendors believe they have found a workaround to the law, saying that they are only selling trinkets and that the cannabis is included. Police call it illegal drug dealing.

A medical marijuana dispensary banned patients for posting complaints on Facebook

A medical marijuana dispensary in western Maryland has banned at least four customers because they posted complaints online about pricing or other issues, sparking concern from advocates and potentially violating state rules for the emerging industry.

Global pharmaceutical giant Novartis teams up with billionaire-backed Canadian marijuana startup

Novartis AG is partnering with a Canadian cannabis company backed by billionaire Peter Thiel to get in on the medical marijuana business.

California’s “outlaw” marijuana culture faces a harsh reckoning: legal weed

“The free market is going to drive people out of those hills. They won’t be able to make money there anymore.”

Navy spending $1 million to investigate surfing as a way to counteract PTSD

Still no federal support for research into whether medical marijuana could help veterans suffering from PTSD, though

Op-ed: Why are police departments still using drug field tests?

A report found that more than half of those wrongly charged after a false positive actually pleaded guilty, an indication of how the threat of serious jail time can persuade innocent people to falsely confess.

Colombia looks to become the world’s supplier of legal marijuana

After an about-face on marijuana, Colombia is looking to exchange gun-toting traffickers for corporate backers to become world leaders in legal cannabis.

Philando Castile used to buy lunch for poor students. That act of kindness didn’t die with him.

In his Minnesota community, Castile was known as “Mr. Phil,” a kind man who supervised the food program in an elementary school cafeteria and knew the children by name.

Marijuana is legal, but D.A.R.E. sticks to its old-school approach

For 16 years, every elementary school student in this small town in Massachusetts has learned about drugs from Officer Kenneth Thaxter. But this year, his lesson needed to change, and he was about to find out whether the students knew why.

Rate of transit workers who fail federal drug tests soars by 77 percent

As the opioid crisis has mushroomed into a national epidemic, the number of truck and bus drivers, commercial pilots, railroad operators and pipeline workers who failed federal drug tests has jumped by 77 percent since 2006, federal data shows.

Dan Morhaim, who helped usher medical marijuana into Maryland then ran into controversy, is retiring

Maryland Del. Dan Morhaim will not seek another term in the General Assembly, ending a 24-year run in which he helped launch the state’s medical marijuana program.

Doctors backing out of recommending medical marijuana in response to Sessions memo

Some doctors who had signed up for medical marijuana programs promptly backed out when Sessions reversed the hands-off policy of the Obama era.

Trump sees ‘carnage’ from American drug use but major cities actually getting safer

Statistics show what appears to be a broad, long-term decoupling of homicide rates and the illegal drug trade in many U.S. cities.

After sounding alarm about increased crime, Sessions credits Trump with crime rate drop in first half of 2017

Sessions is making the case Trump administration anti-crime policies are working, even though the trend already was apparent when he repeatedly warned that crime was out of control.

Marijuana-based anti-seizure drug shows strong study results

Officials from GW Pharmaceuticals, the company that developed Epidiolex announced promising results from a randomized study on 171 patients.

A closer look at the VA’s softer stance on medical marijuana

A new directive from the Veterans Health Administration urges vets and their physicians to open up on the subject of medical marijuana, but whether vets will do so remains to be seen.

Résumé of Trump’s 24-year-old drug policy appointee raising eyebrows

The résumé of Taylor Weyeneth, a rising star in the Trump administration’s Office of National Drug Control Policy, is raising eyebrows in Washington, D.C.

Maryland’s marijuana diversity report released, but what does it mean for minority business owners?

Discrimination in Maryland’s broader business climate justifies giving minority and women-owned businesses preferences for entering the medical marijuana market, according to a report released Wednesday.

VA says it won’t study medical marijuana’s effect on veterans

The Department of Veterans Affairs says it will not conduct research into whether medical marijuana could help veterans suffering from post-traumatic stress disorder and chronic pain.

Meet the 24-year-old Trump campaign worker appointed to help lead the government’s drug policy office

At 23, Taylor Weyeneth, was a political appointee and rising star at the Office of National Drug Control Policy, the White House office responsible for coordinating the federal government’s multibillion dollar anti-drug initiatives.

Study: Legalizing marijuana nationally could generate more than $132 billion in tax revenue and 1 million jobs

Legalizing marijuana nationwide would create at least $132 billion in tax revenue and more than a million new jobs across the United States in the next decade, according to a new study.

Op-ed: Jeff Sessions is a hypocrite on states’ rights. But so is everyone else

As a former senator from the South known for trumpeting the sovereignty of state power over federal overreach, Sessions’ defense of overturning practices that had been initiated by state ballots seems contradictory, even hypocritical.

Anti-marijuana Kansas lawmaker: African Americans more susceptible to drug abuse because of “genetics”

“One of the reasons why, I hate to say it, it’s that the African Americans, they were basically users and they basically responded the worst off those drugs just because their character makeup, their genetics and that.”

Can legal marijuana survive the disapproving glare of Jeff Sessions?

The U.S. is not gearing up for a large-scale prosecution of legal marijuana users, according to initial indications from the dozen or so U.S. attorneys who are now authorized make that call.

Jeff Sessions just injected marijuana into the 2020 presidential race

Democrats from likely to dark horse candidates for their party’s 2020 presidential nomination denounced Sessions’ move to reduce state marijuana protections.

Trump administration angers vulnerable Republicans with marijuana crackdown

With the proposed crackdown on marijuana, the Trump administration created huge political headaches for scores of Republicans who were already facing a tough environment in 2018.

Trump administration must battle public opinion, economics in attack on marijuana

Rolling back marijuana policy is likely to cause political headaches for the Trump administration given widespread public support, the economic clout of the marijuana industry and the supporters legal marijuana businesses have won over in Congress.